Compound traditional Chinese medicine for intervening hepatic fibrosis and preparation method and application thereof
What is Al technical title?
Al technical title is built by PatSnap Al team. It summarizes the technical point description of the patent document.
A compound traditional Chinese medicine, liver fibrosis technology, applied in non-active ingredients medical preparations, active ingredients-containing medical preparations, digestive system and other directions, to achieve good resistance to liver fibrosis, improve bioavailability, reduce drug dosage Effect
Active Publication Date: 2021-09-17
NINGXIA MEDICAL UNIV
View PDF2 Cites 0 Cited by
Summary
Abstract
Description
Claims
Application Information
AI Technical Summary
This helps you quickly interpret patents by identifying the three key elements:
Problems solved by technology
Method used
Benefits of technology
Problems solved by technology
There is currently no drug that can effectively treat HF
Method used
the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more
Image
Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
Click on the blue label to locate the original text in one second.
Reading with bidirectional positioning of images and text.
Smart Image
Examples
Experimental program
Comparison scheme
Effect test
Embodiment 1
[0040] A compound traditional Chinese medicine for intervening liver fibrosis, which is composed of the following raw materials: 10g lizard, 10g angelica root, 10g vinegar Bupleurum, 10g raw white peony root, 20g raw Atractylodes macrocephala, 10g poria cocos, 10g vinegar turtle shell, 20g salvia miltiorrhiza, red peony root 15g, licorice 10g, raw grain buds 20g, raw hawthorn 20g, Yuanhu 10g, antler gum 10g, saponins thorn 20g, ganoderma lucidum 20g, wolfberry 10g, bergamot 10g, ebony 10g.
Embodiment 2
[0042] A compound traditional Chinese medicine for intervening liver fibrosis, which is composed of the following raw materials: 15g lizard, 10g angelica root, 10g vinegar Bupleurum, 10g raw white peony root, 20g raw Atractylodes macrocephala, 10g poria cocos, 10g vinegar turtle shell, 20g salvia miltiorrhiza, red peony root 15g, licorice 10g, raw grain buds 20g, raw hawthorn 20g, Yuanhu 10g, antler gum 10g, saponins thorn 20g, ganoderma lucidum 20g, wolfberry 10g, bergamot 10g, ebony 20g.
Embodiment 3
[0044] A compound traditional Chinese medicine for intervening liver fibrosis, which is composed of the following raw materials: 20g lizard, 20g angelica root, 15g vinegar Bupleurum, 20g raw white peony root, 30g raw Atractylodes macrocephala, 15g poria cocos, 15g vinegar turtle shell, 30g salvia miltiorrhiza, red peony root 30g, licorice 20g, raw grain buds 30g, raw hawthorn 30g, Yuanhu 25g, antler gum 20g, saponins thorn 30g, ganoderma lucidum 30g, wolfberry 20g, bergamot 20g, ebony 20g.
the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more
PUM
Login to view more
Abstract
The invention relates to the technical field of traditional Chinese medicines, and particularly relates to a compound traditional Chinese medicine for intervening hepatic fibrosis and a preparation method thereof. The compound traditional Chinese medicine consists of the following raw materials in parts by weight: 10 to 30 parts of lizard, 10 to 30 parts of radix angelicae sinensis, 10 to 20 parts of vinegar-processed radix bupleuri, 10 to 30 parts of raw radix paeoniae alba, 20 to 50 parts of raw rhizoma atractylodis macrocephalae, 10 to 30 parts of poria cocos, 10 to 30 parts of vinegar-processed turtle shell, 20 to 50 parts of radix salviae miltiorrhizae, 15 to 45 parts of radix paeoniae rubra, 10 to 30 parts of liquorice root, 20 to 50 parts of raw rice sprout, 20 to 40 parts of raw fructus crataegi, 10 to 30 parts of rhizoma corydalis, 10 to 30 parts of deer-horn glue, 20 to 50 parts of spina gleditsiae, 20 to 50 parts of lucid ganoderma, 10 to 30 parts of fructus lycii, 10 to 30 parts of fingered citron, and 10-30 parts of fructus mume. The compound preparation has a remarkable curative effect on hepatic fibrosis caused by deficiency of liver blood and stasis of veins.
Description
technical field [0001] The invention relates to the technical field of traditional Chinese medicines, in particular to a compound traditional Chinese medicine for intervening liver fibrosis, a preparation method and application thereof. Background technique [0002] Hepatic fibrosis (hepatic fibrosis, HF) is a pathological change that exists in most chronic liver diseases. changes and affect their normal physiological functions. HA, LN, PC-Ⅲ and Ⅳ-C are all important components of ECM. When liver fibrosis occurs, the content of HA, LN, PC-Ⅲ and Ⅳ-C in serum will increase correspondingly. The clinical detection of liver fibrosis can also express the severity of liver fibrosis. There is currently a lack of a drug that can effectively treat HF. Contents of the invention [0003] The object of the present invention is to provide a compound traditional Chinese medicine for intervening liver fibrosis and a preparation method thereof. [0004] In order to achieve the above-me...
Claims
the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more
Application Information
Patent Timeline
Application Date:The date an application was filed.
Publication Date:The date a patent or application was officially published.
First Publication Date:The earliest publication date of a patent with the same application number.
Issue Date:Publication date of the patent grant document.
PCT Entry Date:The Entry date of PCT National Phase.
Estimated Expiry Date:The statutory expiry date of a patent right according to the Patent Law, and it is the longest term of protection that the patent right can achieve without the termination of the patent right due to other reasons(Term extension factor has been taken into account ).
Invalid Date:Actual expiry date is based on effective date or publication date of legal transaction data of invalid patent.
Login to view more 
Login to view more